Roehlen N, Muller M, Nehme Z, Crouchet E, et al. Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment. J Hepatol 2023;78:343-355.
PMID: 36309131